Consumers at Risk: Recalled Baby Formula Found on Store Shelves

A recent incident involving the sale of recalled baby formula has raised significant concerns about product safety. On December 12, 2023, the US Food and Drug Administration (FDA) issued warnings to several retailers, including Kroger, Target, Albertsons, and Walmart, after inspectors discovered cans of ByHeart powdered infant formula on store shelves across 36 states, despite an active recall.

The alarm was first sounded when a shopper noticed a can of ByHeart formula on the shelf of a Kroger store, still displaying a recall notice from November. This prompted a swift reaction from food safety attorney Bill Marler, who is representing families affected by the recall. Marler was in the process of amending complaints against retailers for not acting quickly enough to remove the dangerous product from their shelves.

Kroger responded to the shopper’s concerns, stating, “When the recall was issued, we urgently removed the affected product and immediately placed a block at the point of sale to make it impossible for a customer to purchase the recalled item.” Despite this assurance, questions remain about how the product remained available for purchase.

The FDA’s warnings were part of a broader concern about the difficulty retailers face in completely removing recalled products from inventory. According to Peter Feldman, acting chairman of the Consumer Product Safety Commission (CPSC), the agency has encountered numerous cases where recalled items linger on shelves. He noted that the CPSC secured a $13 million penalty from TJX, the parent company of TJ Maxx, HomeGoods, and Marshalls, for selling over 1,200 units of recalled items, including dangerous infant sleepers.

Feldman explained that communication failures and lax compliance can contribute to the persistence of recalled products in stores. He cited instances where retailers have shut off inventory control software during busy sales periods, allowing recalled goods to be sold without detection.

The CPSC and FDA undertake periodic checks to ensure recalled products are not available to consumers. In the past three months, the CPSC’s ESAFE team has issued 33,000 takedown orders for online sales of recalled products, a substantial increase compared to previous periods. Feldman pointed out that baby products and electronics are particularly scrutinized due to their potential risks.

The case of ByHeart has broader implications. The company recalled all lots of its Whole Nutrition powdered infant formula on November 11, 2023, after investigations by the California Department of Public Health, the FDA, and the CDC linked it to an uptick in infant botulism cases. By December 17, the FDA reported 51 infants across 19 states had been affected, all of whom were hospitalized. Fortunately, no fatalities have been recorded, largely due to the availability of Baby Botulism Immune Globulin intravenous (BabyBIG), which helps counteract the effects of botulinum toxin.

Despite these measures, the potential long-term health impacts on affected infants remain a concern. Health experts emphasize the importance of rapid and effective recall processes to prevent further harm. Frank Yiannis, former FDA deputy commissioner, criticized both ByHeart and regulatory bodies for their slow response to the outbreak. He noted that the initial recall only involved two lots of formula, which likely confused retailers and delayed the removal of all affected products.

In response to the ongoing crisis, ByHeart announced they have paused production and are conducting a thorough audit of their supply chain. They expressed regret for the distress caused to customers and partners and continue to urge parents to monitor their infants closely for symptoms of botulism.

As the situation unfolds, experts continue to advocate for enhanced regulatory measures and the adoption of technology to better track products throughout the supply chain. Yiannis suggested that implementing RFID tags could significantly improve tracking and recall processes, ensuring that dangerous products do not remain on store shelves.

The ByHeart incident serves as a stark reminder of the responsibilities retailers and manufacturers hold in safeguarding public health. As recalls become more frequent, it is crucial for consumers to remain vigilant and informed, particularly regarding products intended for vulnerable populations like infants.